Alternative Data for Edwards Lifesciences
About Edwards Lifesciences
Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient's diseased or defective heart valve.
| Price | $83.66 |
| Target Price | Sign up |
| Volume | 2,850,000 |
| Market Cap | $49.1B |
| Year Range | $72.65 - $86.94 |
| Dividend Yield | 0% |
| PE Ratio | 37.02 |
| Analyst Rating | 45% buy |
| Industry | Medical Devices |
In the news
Edwards Lifesciences Corp. stock outperforms competitors on strong trading dayJanuary 21 - MarketWatch |
|
 |
Edwards Lifesciences price target raised by $5 at Stifel, here's whyJanuary 20 - Thefly.com |
|
Edwards Lifesciences price target raised by $3 at Piper Sandler, here's whyJanuary 20 - Thefly.com |
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitorsJanuary 20 - MarketWatch |
|
Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential?January 19 - Yahoo Entertainment |
|
 |
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?January 18 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 1.55B | 345M | 1.21B | 291M | 388M | 0.670 |
| Q2 '25 | 1.53B | 343M | 1.19B | 330M | 400M | 0.670 |
| Q1 '25 | 1.41B | 302M | 1.11B | 358M | 471M | 0.640 |
| Q4 '24 | 1.39B | 292M | 1.09B | 386M | 484M | 0.590 |
| Q3 '24 | 1.35B | 263M | 1.09B | 3.07B | 429M | 0.670 |
Insider Transactions View All
| Lippis Daniel J. filed to sell 22,002 shares at $85.7. January 9 '26 |
| BOBO DONALD E JR filed to sell 40,578 shares at $84.6. January 6 '26 |
| BOBO DONALD E JR filed to sell 31,870 shares at $86. January 6 '26 |
| STONE HEISZ LESLIE filed to sell 30,948 shares at $83.4. December 12 '25 |
| Lippis Daniel J. filed to sell 22,002 shares at $84. December 12 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer |
Dec 30, 25 | Sell | $1K - $15K |
| Bruce Westerman |
May 13, 25 | Sell | $1K - $15K |
| Jefferson Shreve |
May 9, 25 | Buy | $15K - $50K |
Read more about Edwards Lifesciences (EW) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
FAQ - Edwards Lifesciences
The Market Cap of Edwards Lifesciences is $49.1B.
As of today, Edwards Lifesciences' PE (Price to Earnings) ratio is 37.02.
Currently, the price of one share of Edwards Lifesciences stock is $83.66.
The EW stock price chart above provides a comprehensive visual representation of Edwards Lifesciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Edwards Lifesciences shares. Our platform offers an up-to-date EW stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Edwards Lifesciences (EW) does not offer dividends to its shareholders. Investors interested in Edwards Lifesciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Edwards Lifesciences are Boston Scientific, Intuitive Surgical, Medtronic, Stryker, and Becton Dickinson and Co.
